AMH (Anti-Müllerian Hormone) is often marketed as a marker for ovarian reserve, but its usefulness for menopause (Wechseljahre) is limited. Studies show that AMH correlates with the timing of menopause, but it is not precise enough to predict individual onset. Menopause is clinically defined by the absence of menstruation for 12 months, not by a blood value. AMH can be helpful for fertility questions, but for pure menopause determination it is not a reliable biomarker. Additionally, reference ranges vary by lab and test method. For women in menopause, symptoms and cycle changes are more informative. An AMH test can provide additional information but should not be used as a sole diagnostic tool. The evidence is moderate, and many professional societies advise against routine AMH screening for menopause.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-82f2669329a2319c78305ead